BBC BioShares Biotechnology Clinical Trials ETF

Seeks to track, before fees and expenses, the LifeSci Biotechnology Clinical Trials Index. The Index is an equal weighted index that is designed to measure the equity market performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering that is in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development.

$18.83  +0.08 (0.43%)
As of 05/26/2022 16:00:00 EST     IEX book   CBOE book

---

ETF Information

---

Sponsor:     Virtus ETF Solutions
Category1:  US Equity
Category2:  Single industry
Category3:  Biotechnology
Morningstar category:  Health
Leverage factor:  1.00
Inception date:  12/16/2014
Index tracking method: Passive replication
Current yield:  0.00%
Historical average yield:  0.19%
Market cap:  $14,061,000
Average volume:  4,437
Fees:     0.7900%

---

Index Information

---

LifeSci Biotechnology Clinical Trials Index
Index symbol:  LSCIBC
Provider:   LifeSci Index Partners
Index weighting:   Equal weighted
Index inception date:  11/03/2014
Backtesting data exists:   Yes
Number of holdings:  94  (as of 02/28/2019)
Strategy:  Equal weighting